Varaico: Literature-Extracted Genetic Variants

Gene:APC
Variant:p.E853*
Back to variants list

APC

NM_000038.6:p.E853*

Associated Papers

Common gene mutations in 103 authenticated colorectal cancer cell lines.

Kranjec C et al.

Oncogenesis, 2026

41593049 (PubMed )
Supplement: 41389_2026_599_MOESM2_ESM.xlsx › Supplementary_Table_10

Decay of driver mutations shapes the landscape of intestinal transformation.

Lourenço FC et al.

Nature, 2026

41339549 (PubMed )
Supplement: 41586_2025_9762_MOESM11_ESM.xlsx › ED_Fig_3g

A base editing platform for the correction of cancer driver mutations unmasks conserved p53 transcription programs.

Wang P et al.

Genome Biology, 2025

40696461 (PubMed )
Supplement: 13059_2025_3667_MOESM1_ESM.xlsx › Overlap_between_lines

Comprehensive Evaluation of a 1021-Gene Panel in FFPE and Liquid Biopsy for Analytical and Clinical Use.

Meintani A et al.

International Journal of Molecular Sciences, 2025

40649709 (PubMed )
Supplement: ijms-26-05930-s001.zip › Supplementary_Table_2_and_Figure_S1.xlsx › Table_S3

HDAC and MEK inhibition synergistically suppresses HOXC6 and enhances PD-1 blockade efficacy in BRAFV600E-mutant microsatellite stable colorectal cancer.

Sun Z et al.

Journal for Immunotherapy of Cancer, 2025

39800382 (PubMed )
Supplement: jitc-13-1-s001.pdf

Genomic characterization reveals distinct mutation landscapes and therapeutic implications in neuroendocrine carcinomas of the gastrointestinal tract.

Wu H et al.

Cancer Communications (london, England), 2022

36264285 (PubMed )
Supplement: CAC2-42-1367-s002.xlsx › Supplementary_Table_S3

The neuronal protein Neuroligin 1 promotes colorectal cancer progression by modulating the APC/β-catenin pathway.

Pergolizzi M et al.

Journal of Experimental & Clinical Cancer Research : Cr, 2022

HER2 G776S mutation promotes oncogenic potential in colorectal cancer cells when accompanied by loss of APC function.

Mitani Y et al.

Scientific Reports, 2022

35654814 (PubMed )
Supplement: 41598_2022_13189_MOESM1_ESM.docx

Rearrangement-mediated cis-regulatory alterations in advanced patient tumors reveal interactions with therapy.

Zhang Y et al.

Cell Reports, 2021

34788622 (PubMed )
Supplement: NIHMS1757901-supplement-2.xlsx › SNVs_indels

A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.

Xiao J et al.

Bmc Cancer, 2021

33726687 (PubMed )
Supplement: 12885_2021_7942_MOESM3_ESM.xlsx › Table_S2

Integrated genetic and epigenetic analysis of cancer-related genes in non-ampullary duodenal adenomas and intramucosal adenocarcinomas.

Ota R et al.

The Journal of Pathology, 2020

32770675 (PubMed )
Supplement: PATH-252-330-s002.xlsx › Table_S6

The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis.

Tu J et al.

Scientific Reports, 2019

31811196 (PubMed )
Supplement: 41598_2019_54931_MOESM1_ESM.pdf

Serum starvation enhances nonsense mutation readthrough.

Wittenstein A et al.

Journal of Molecular Medicine (berlin, Germany), 2019

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer-The Impact in Intratumoral Heterogeneity.

Bettoni F et al.

Frontiers in Oncology, 2019

31612112 (PubMed )
Supplement: Table_4.XLSX › Supplementary_Table_4

CHK1-targeted therapy to deplete DNA replication-stressed, p53-deficient, hyperdiploid colorectal cancer stem cells.

Manic G et al.

Gut, 2018

28389531 (PubMed )
Supplement: gutjnl-2016-312623supp002.pdf

A molecular inversion probe-based next-generation sequencing panel to detect germline mutations in Chinese early-onset colorectal cancer patients.

Zhang J et al.

Oncotarget, 2017

APC Mutations as a Potential Biomarker for Sensitivity to Tankyrase Inhibitors in Colorectal Cancer.

Tanaka N et al.

Molecular Cancer Therapeutics, 2017

Blocking Wnt Secretion Reduces Growth of Hepatocellular Carcinoma Cell Lines Mostly Independent of β-Catenin Signaling.

Wang W et al.

Neoplasia (new York, N.y.), 2016

The ratio of STAT1 to STAT3 expression is a determinant of colorectal cancer growth.

Nivarthi H et al.

Oncotarget, 2016

27191495 (PubMed )
Supplement: oncotarget-07-51096-s001.pdf

Target enrichment using parallel nanoliter quantitative PCR amplification.

De Wilde B et al.

Bmc Genomics, 2014

Abnormality in Wnt signaling is causatively associated with oxidative stress-induced intestinal tumorigenesis in MUTYH-null mice.

Isoda T et al.

International Journal of Biological Sciences, 2014

CEA/CD3 bispecific antibody MEDI-565/AMG 211 activation of T cells and subsequent killing of human tumors is independent of mutations commonly found in colorectal adenocarcinomas.

Oberst MD et al.

Mabs, 2014

25484061 (PubMed )
Supplement: kmab-06-06-975660-s001.zip › Supplementary_Figure_2.pdf

Pharmaceutical therapies to recode nonsense mutations in inherited diseases.

Lee HL et al.

Pharmacology & Therapeutics, 2012

Recurrent R-spondin fusions in colon cancer.

Seshagiri S et al.

Nature, 2012

Combined molecular genetic and cytogenetic analysis from single cells after isothermal whole-genome amplification.

Kroneis T et al.

Clinical Chemistry, 2011

Readthrough of premature termination codons in the adenomatous polyposis coli gene restores its biological activity in human cancer cells.

Floquet C et al.

Plos One, 2011

Mutation analysis of 24 known cancer genes in the NCI-60 cell line set.

Ikediobi ON et al.

Molecular Cancer Therapeutics, 2006

Nuclear accumulation of full-length and truncated adenomatous polyposis coli protein in tumor cells depends on proliferation.

Fagman H et al.

Oncogene, 2003

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."